Results 11 to 20 of about 127,271 (293)

Mitochondrial cardiomyopathies [PDF]

open access: yesFrontiers in Cardiovascular Medicine, 2016
Mitochondria are found in all nucleated human cells and perform a variety of essential functions, including the generation of cellular energy. Mitochondria are under dual genome control.
Ayman W. El-Hattab, Fernando Scaglia
doaj   +3 more sources

Reversible Cardiomyopathies

open access: yesClinical Medicine Insights: Cardiology, 2015
Cardiomyopathies (CMs) have many etiological factors that can result in severe structural and functional dysregulation. Fortunately, there are several potentially reversible CMs that are known to improve when the root etiological factor is addressed.
Harsh Patel   +4 more
doaj   +4 more sources

Cardiomyopathies

open access: yesAutoimmunity, 2004
Cardiomyopathies include a wide variety of cardiac diseases. The value of MR imaging is not only to provide information about cardiac function, but also to detect the underlying cause of the disease.
Noel R, Rose, Daniela, Cihakova
openaire   +4 more sources

Stress Cardiomyopathy (Takotsubo Cardiomyopathy) [PDF]

open access: yesClinical medicine. Cardiology, 2009
Background Due to the rise in the number of reports of stress cardiomyopathy in the literature, awareness of this condition is increasing. Although different names have been used to describe this condition, the similarities in clinical, electrocardiographic, echocardiographic and angiographic features suggest that they represent the same spectrum of ...
Samer Khouri, Naser Imran
openaire   +3 more sources

Arrhythmogenic Cardiomyopathy [PDF]

open access: yesCirculation Research, 2017
Arrhythmogenic cardiomyopathy is an inherited heart muscle disorder, predisposing to sudden cardiac death, particularly in young patients and athletes. Pathological features include loss of myocytes and fibrofatty replacement of right ventricular myocardium; biventricular involvement is often observed.
Corrado, Domenico   +2 more
openaire   +3 more sources

Cardiomyopathies.

open access: yesActa bio-medica : Atenei Parmensis, 2019
The most common cardiomyopathies often present to primary care physicians with similar symptoms, despite the fact that they involve a variety of phenotypes and etiologies (1). Many have signs and symptoms common in heart failure, such as reduced ejection fraction, peripheral edema, fatigue, orthopnea, exertion dyspnea, paroxysmal nocturnal dyspnea ...
Precone, Vincenza   +9 more
openaire   +2 more sources

Targeting lipid metabolism as a new therapeutic strategy for inherited cardiomyopathies

open access: yesFrontiers in Cardiovascular Medicine, 2023
Inherited cardiomyopathies caused by pathological genetic variants include multiple subtypes of heart disease. Advances in next-generation sequencing (NGS) techniques have allowed for the identification of numerous genetic variants as pathological ...
Karen R. Gaar-Humphreys   +16 more
doaj   +1 more source

Eclipsed Functional Mitral Regurgitation Destabilizing Hypertrophic Cardiomyopathy: An Unusual Case Treated With MitraClipNovel Teaching Points

open access: yesCJC Open, 2021
MitraClip (Abbott Laboratories, Abbott Park, IL) is validated in high-risk patients with severe degenerative mitral regurgitation (MR); however, it is not well established for functional MR in hypertrophic cardiomyopathy (HCM).
Catherine Bourque, MD   +8 more
doaj   +1 more source

Transcriptome data analysis of primary cardiomyopathies reveals perturbations in arachidonic acid metabolism

open access: yesFrontiers in Cardiovascular Medicine, 2023
IntroductionCardiomyopathies are complex heart diseases with significant prevalence around the world. Among these, primary forms are the major contributors to heart failure and sudden cardiac death.
Pankaj Kumar Chauhan   +3 more
doaj   +1 more source

A very rare cause of pre‐capillary pulmonary hypertension: The PAMI syndrome

open access: yesPulmonary Circulation, 2023
We report the first known case of PAMI syndrome associated with pulmonary arterial hypertension (PAH) with a positive response to cyclophosphamide and pulmonary vasodilators. The patient's history began at 7 months with severe pancytopenia and fever.
Manuela Iseppi   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy